Psychedelics
Could Ketamine Help Treat Severe Depression?
Researchers from Trinity and St Patrick’s Mental Health Services are trialling a new treatment regime using ketamine for people who are experiencing severe depression.
LSD “Frees the Brain” From Its Usual Neural Pathways, Study Finds
The researchers also found that the drug increased the complexity of only certain brain states, known as segregated brain states.
Massachusetts General Hospital Launches New Center for Psychedelics
Analytical Cannabis spoke to Jerrold F. Rosenbaum, director of the Center for the Neuroscience of Psychedelics, to learn more about its research ambitions.
Single Dose of Psilocybin Can Remodel the Brains of Mice, Study Finds
The new study examined structural changes in the brain that might explain psilocybin’s enduring antidepressant effects.
Process By Which Ketamine Acts as an Antidepressant Confirmed
Ketamine can provide rapid antidepressant relief in as little as two hours that can be sustained for days to weeks.
Laughing Gas Relieves Symptoms of Treatment-Resistant Depression, New Study Finds
Results from a new clinical trial indicate that inhaling a mixture of 25 percent nitrous oxide and oxygen can provide long-lasting relief to those who have found other antidepressants ineffective.
More Than One-Third of Americans Support Psychedelics Legalization, New Poll Finds
The survey also found that 75 percent of respondents now support cannabis legalization for all purposes, with just 5 percent opposed to both recreational and medical legalization.
MDMA-assisted Therapy Can Successfully Treat PTSD, Study Finds
The use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) has now proven itself in its first phase 3 clinical trial.
Synthetic Psychedelic Reduces Stress in Mice, Study Finds
Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.
